Adverse events645

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 645

Type	Event	Organ system	Group	Affected	At risk	Events
other	Anaemia	Blood and lymphatic system disorders	Arm A: Treatment Period- SOC	47	104	63
other	Anaemia	Blood and lymphatic system disorders	Arm B: Treatment Period- Pralsetinib	52	108	71
other	Anaemia	Blood and lymphatic system disorders	Arm C: Crossover Period- Pralsetinib	10	38	13
other	Leukopenia	Blood and lymphatic system disorders	Arm A: Treatment Period- SOC	5	104	5
other	Leukopenia	Blood and lymphatic system disorders	Arm B: Treatment Period- Pralsetinib	13	108	16
other	Leukopenia	Blood and lymphatic system disorders	Arm C: Crossover Period- Pralsetinib	2	38	2
other	Lymphopenia	Blood and lymphatic system disorders	Arm A: Treatment Period- SOC	2	104	2
other	Lymphopenia	Blood and lymphatic system disorders	Arm B: Treatment Period- Pralsetinib	6	108	7
other	Lymphopenia	Blood and lymphatic system disorders	Arm C: Crossover Period- Pralsetinib	3	38	4
other	Neutropenia	Blood and lymphatic system disorders	Arm A: Treatment Period- SOC	19	104	31
other	Neutropenia	Blood and lymphatic system disorders	Arm B: Treatment Period- Pralsetinib	27	108	46
other	Neutropenia	Blood and lymphatic system disorders	Arm C: Crossover Period- Pralsetinib	7	38	23
other	Thrombocytopenia	Blood and lymphatic system disorders	Arm A: Treatment Period- SOC	12	104	17
other	Thrombocytopenia	Blood and lymphatic system disorders	Arm B: Treatment Period- Pralsetinib	3	108	3
other	Thrombocytopenia	Blood and lymphatic system disorders	Arm C: Crossover Period- Pralsetinib	0	38	0
other	Hypothyroidism	Endocrine disorders	Arm A: Treatment Period- SOC	9	104	10
other	Hypothyroidism	Endocrine disorders	Arm B: Treatment Period- Pralsetinib	4	108	4
other	Hypothyroidism	Endocrine disorders	Arm C: Crossover Period- Pralsetinib	1	38	1
other	Dry eye	Eye disorders	Arm A: Treatment Period- SOC	4	104	4
other	Dry eye	Eye disorders	Arm B: Treatment Period- Pralsetinib	1	108	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04222972/events

API reference For AI assistants

Adverse events645

Sources 3

Read this list from software.